Crowd Funding for Orphan Drugs: The Case of Baby Pia
Author:
Open Access
- 14 December 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 12, 787342
Abstract
Medical crowdfunding is a relatively new strategy to obtain access to orphan drugs. The case of Baby Pia, a Belgian girl with SMA type 1 for whom in 2018 more than $ 2.1 million was raised to get her treated with Zolgensma®, illustrates well the potential power of medical crowdfunding. But apart from the success in raising money, the case is also of particular importance for the ethical issues it brings to the surface as related to justice, equity, power imbalances, responsibility, accountability, indebtedness and privacy.Keywords
This publication has 9 references indexed in Scilit:
- Bioethics and the use of social media for medical crowdfundingBMC Medical Ethics, 2020
- Crowdfunding Campaigns and Thyroid Surgery: Who, What, Where, and How Much?Journal of Surgical Research, 2020
- “We don’t want him worrying about how he will pay to save his life”: Using medical crowdfunding to explore lived experiences with addiction services in CanadaInternational Journal of Drug Policy, 2019
- Crowdfunding our health: Economic risks and benefitsSocial Science & Medicine, 2017
- Producing a worthy illness: Personal crowdfunding amidst financial crisisSocial Science & Medicine, 2017
- Appealing to the crowd: ethical justifications in Canadian medical crowdfunding campaignsJournal of Medical Ethics, 2017
- Crowdfunding FOR MEDICAL CARE: Ethical Issues in an Emerging Health Care Funding PracticeHastings Center Report, 2016
- Fund my treatment!: A call for ethics-focused social science research into the use of crowdfunding for medical careSocial Science & Medicine, 2016
- Crowdfunding for medical expensesCanadian Medical Association Journal, 2012